A Blaine Bowman
CIK 1008891 · last filed 2026-05-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ILMN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
6600 DUMBARTON CIRCLE
FREMONT, CA 94555
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PSNL | Director | 19,756 | $15.82 | $312.5K | $0 | 7 | 2026-05-14 |
| ILMN | Director | 16,144 | $269.40 | $4.35M | -$21.89M | 44 | 2018-05-24 |
| ALTERA CORP (ALTR) Delisted | Director | 8,551 | $111.85 | $956.4K | $0 | 4 | 2015-05-12 |
| DIONEX CORP /DE (DNEX) Delisted | Director | 0 | — | — | -$3.96M | 11 | 2011-05-18 |
| MOLECULAR DEVICES CORP (MDCC) Delisted | Director | 4,000 | — | — | $0 | 2 | 2007-03-27 |
Recent Filings · Page 7 of 8
71 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-05-20 | ILMN | Grant (A) | +1,000 | $0 | EDGAR |
| 2007-11-30 | DIONEX CORP /DE (DNEX) Delisted | Gift (G) | −9,300 | -$794.3K | EDGAR |
| 2007-11-01 | DIONEX CORP /DE (DNEX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-08-31 | DIONEX CORP /DE (DNEX) Delisted | Sell (S) | −13,374 | -$975.3K | EDGAR |
| 2007-08-31 | DIONEX CORP /DE (DNEX) Delisted | Sell (S) | −16,626 | -$1.21M | EDGAR |
| 2007-05-09 | DIONEX CORP /DE (DNEX) Delisted | Sell (S) | −4,503 | -$320.8K | EDGAR |
| 2007-05-09 | DIONEX CORP /DE (DNEX) Delisted | Sell (S) | −20,497 | -$1.45M | EDGAR |
| 2007-03-27 | MOLECULAR DEVICES CORP (MDCC) Delisted | Mixed | +4,000 | -$485.6K | EDGAR |
| 2007-03-20 | MOLECULAR DEVICES CORP (MDCC) Delisted | U | −40,000 | -$1.42M | EDGAR |
| 2007-02-01 | ILMN | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.